Literature DB >> 11867204

Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors.

Masaharu Akiyama1, Osamu Yamada, Naotoshi Kanda, Shinobu Akita, Takeshi Kawano, Tsuneya Ohno, Hideaki Mizoguchi, Yoshikatsu Eto, Kenneth C Anderson, Hisashi Yamada.   

Abstract

Telomeres are specialized DNA/protein structures that act as protective caps to prevent end fusions. The maintenance of telomeres is essential for chromosomal stability. Telomerase is regulated by human telomerase reverse transcriptase (hTERT). c-Myc oncoprotein is also implicated in the positive regulation of hTERT expression. We show here that two clones of hTERT-transfected K562 erythroleukemia cells have elongated telomeres (22.5 and 24.0 kb), whereas telomere length of both c-Myc-transfected K562 cells and parental K562 cells is 6.5 kb. Telomerase activity and hTERT mRNA expression increased in hTERT-transfected K562 cells, while the expression levels of telomerase activity and hTERT in c-Myc-transfected K562 cells were similar to that in parental K562 cells, despite an overexpression of c-Myc. Importantly, we found that hTERT-transfected K562 cells are protected against apoptosis induced by serum deprivation and double-stranded DNA break inducing agents (ionizing irradiation, and etoposide (VP-16)), but not against DNA synthesis inhibitors (1-beta-D-arabinofuranosylcytosine and hydroxyurea). These findings suggest that overexpression of telomerase by transfecting hTERT confers telomere-elongation and resistance to double-stranded DNA break inducing agents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867204     DOI: 10.1016/s0304-3835(01)00838-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  22 in total

1.  A chemical enucleation method for the transfer of mitochondrial DNA to rho(o) cells.

Authors:  Maria Pilar Bayona-Bafaluy; Giovanni Manfredi; Carlos T Moraes
Journal:  Nucleic Acids Res       Date:  2003-08-15       Impact factor: 16.971

2.  Mechanism of telomerase activation by v-Rel and its contribution to transformation.

Authors:  Radmila Hrdlicková; Jirí Nehyba; Andrew S Liss; Henry R Bose
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

3.  Expression of (NES-)hTERT in cancer cells delays cell cycle progression and increases sensitivity to genotoxic stress.

Authors:  Olga A Kovalenko; Jessica Kaplunov; Utz Herbig; Sonia Detoledo; Edouard I Azzam; Janine H Santos
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

Review 4.  Tea polyphenols, their biological effects and potential molecular targets.

Authors:  D Chen; V Milacic; M S Chen; S B Wan; W H Lam; C Huo; K R Landis-Piwowar; Q C Cui; A Wali; T H Chan; Q P Dou
Journal:  Histol Histopathol       Date:  2008-04       Impact factor: 2.303

5.  DNA damage induces N-acetyltransferase NAT10 gene expression through transcriptional activation.

Authors:  Haijing Liu; Yun Ling; Yilei Gong; Ying Sun; Lin Hou; Bo Zhang
Journal:  Mol Cell Biochem       Date:  2006-12-16       Impact factor: 3.842

6.  Telomere DNA deficiency is associated with development of human embryonic aneuploidy.

Authors:  Nathan R Treff; Jing Su; Deanne Taylor; Richard T Scott
Journal:  PLoS Genet       Date:  2011-06-30       Impact factor: 5.917

7.  Cellular players in the herpes simplex virus dependent apoptosis balancing act.

Authors:  Marie L Nguyen; John A Blaho
Journal:  Viruses       Date:  2009-11-18       Impact factor: 5.048

8.  Radiolabeled Oligonucleotides Targeting the RNA Subunit of Telomerase Inhibit Telomerase and Induce DNA Damage in Telomerase-Positive Cancer Cells.

Authors:  Mark R Jackson; Bas M Bavelaar; Philip A Waghorn; Martin R Gill; Afaf H El-Sagheer; Tom Brown; Madalena Tarsounas; Katherine A Vallis
Journal:  Cancer Res       Date:  2019-07-16       Impact factor: 13.312

9.  The MAPK pathway signals telomerase modulation in response to isothiocyanate-induced DNA damage of human liver cancer cells.

Authors:  Evelyn Lamy; Corinna Herz; Sabine Lutz-Bonengel; Anke Hertrampf; Melinda-Rita Márton; Volker Mersch-Sundermann
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

10.  Telomere profiling: toward glioblastoma personalized medicine.

Authors:  Sylvain Ferrandon; Paul Saultier; Julien Carras; Priscillia Battiston-Montagne; Gersende Alphonse; Michael Beuve; Céline Malleval; Jérôme Honnorat; Tania Slatter; Noelyn Hung; Janice Royds; Claire Rodriguez-Lafrasse; Delphine Poncet
Journal:  Mol Neurobiol       Date:  2012-10-12       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.